Advanced search
1 file | 561.94 KB

Synthetic cannabinoids: general considerations

Nik De Brabanter (UGent) , Koen Deventer (UGent) , Veronique Stove (UGent) and Peter Van Eenoo (UGent)
Author
Organization
Abstract
Around 2008 synthetic cannabinoids were found to be present in and responsible for the psychoactive effects of herbal mixtures with names like ‘Spice’ or ‘K2’. In response to the increased popularity of these products, (inter)national organizations and governments started banning these cannabimimetics gradually. However, the lack of an uniform and international regulation makes it hard to control this issue. For the different types of synthetic cannabinoids the scientific knowledge in terms of pharmacokinetics and pharmacodynamics is limited. This also means that little is known on the health of users, both on short and long term. In the last years effort has been made to make detection of these products possible in different biological matrices. However, since the number of cannabimimetic compounds on the market appears to grow every month, both scientist and legislators run after a moving target.
Keywords
pharmacokinetics, Spice, legislation, pharmacodynamics, Synthetic cannabinoids

Downloads

  • De Brabanter - Synthetic cannabinoids general considerations.pdf
    • full text
    • |
    • open access
    • |
    • PDF
    • |
    • 561.94 KB

Citation

Please use this url to cite or link to this publication:

Chicago
De Brabanter, Nik, Koen Deventer, Veronique Stove, and Peter Van Eenoo. 2013. “Synthetic Cannabinoids: General Considerations.” Proceedings of the Belgian Royal Academies of Medicine 2: 209–225.
APA
De Brabanter, N., Deventer, K., Stove, V., & Van Eenoo, P. (2013). Synthetic cannabinoids: general considerations. PROCEEDINGS OF THE BELGIAN ROYAL ACADEMIES OF MEDICINE, 2, 209–225.
Vancouver
1.
De Brabanter N, Deventer K, Stove V, Van Eenoo P. Synthetic cannabinoids: general considerations. PROCEEDINGS OF THE BELGIAN ROYAL ACADEMIES OF MEDICINE. 2013;2:209–25.
MLA
De Brabanter, Nik, Koen Deventer, Veronique Stove, et al. “Synthetic Cannabinoids: General Considerations.” PROCEEDINGS OF THE BELGIAN ROYAL ACADEMIES OF MEDICINE 2 (2013): 209–225. Print.
@article{4092714,
  abstract     = {Around 2008 synthetic cannabinoids were found to be present in and responsible for the psychoactive effects of herbal mixtures with names like {\textquoteleft}Spice{\textquoteright} or {\textquoteleft}K2{\textquoteright}. In response to the increased popularity of these products, (inter)national organizations and governments started banning these cannabimimetics gradually. However, the lack of an uniform and international regulation makes it hard to control this issue. 
For the different types of synthetic cannabinoids the scientific knowledge in terms of pharmacokinetics and pharmacodynamics is limited. This also means that little is known on the health of users, both on short and long term. 
In the last years effort has been made to make detection of these products possible in different biological matrices. However, since the number of cannabimimetic compounds on the market appears to grow every month, both scientist and legislators run after a moving target.},
  author       = {De Brabanter, Nik and Deventer, Koen and Stove, Veronique and Van Eenoo, Peter},
  issn         = {2034-7626},
  journal      = {PROCEEDINGS OF THE BELGIAN ROYAL ACADEMIES OF MEDICINE},
  keyword      = {pharmacokinetics,Spice,legislation,pharmacodynamics,Synthetic cannabinoids},
  language     = {eng},
  pages        = {209--225},
  title        = {Synthetic cannabinoids: general considerations},
  volume       = {2},
  year         = {2013},
}